Patients can accelerate the drug development and treatment process by registering for Friedreich’s Ataxia Global Patient Registry. Being part of the registry is a great opportunity to keep updated on what is happening and to participate in clinical trials possibly. It is very important that all FA patients are represented in the patient registry.